Effects of antilymphocyte serum on the induction of neoplasms of lymphoreticular tissues.
D000818:Animals; D000941:Antigens; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D003238:Connective Tissue / Q000276:immunology; D004267:DNA Viruses / Q000276:immunology; D007108:Immune Tolerance; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D009052:Leukemia Virus, Murine / Q000276:immunology* / Q000472:pathogenicity; D007942:Leukemia, Experimental / Q000276:immunology*; D007945:Leukemia, Lymphoid / Q000276:immunology; D008099:Liver / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008223:Lymphoma / Q000276:immunology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology; D051379:Mice; D013154:Spleen / Q000473:pathology; D014779:Virus Replication
D000941:Antigens; D000961:Antilymphocyte Serum; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents